Navigation Links
Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
Date:9/10/2007

) status.

-- Abstract #87

Poster presentation: ER and PR Assessment in ECOG 2197; Comparison of

Locally Determined IHC with Centrally Determined IHC and Quantitative

RT-PCR

Presenter: Sunil S. Badve, M.D.

Summary: A comparison of IHC and quantitative RT-PCR by Oncotype DX

demonstrated a high degree of agreement for measuring ER, PR and HR

status.

-- Abstract #106

Poster presentation: Use of Estrogen Receptor (ER) Expression by

Quantitative RT-PCR to Identify an ER Negative Subgroup by IHC Who

Might Benefit from Hormonal Therapy

Presenter: Luca Gianni, M.D.

Summary: Independent investigators compared quantitative RT-PCR by

Oncotype DX, DNA microarrays, and IHC for measuring ER status.

-- Abstract #27

Oral presentation: Association of Individual Genes with

Risk of Relapse in Operable Breast Cancer: Analysis of E2197

Presenter: Joseph Sparano, M.D.

Summary: Further examination of the Eastern Cooperative Oncology Group

E2197 study identifies multiple genes, including the 21 in Oncotype DX,

that affect the recurrence risk following chemotherapy treatment.

About Oncotype DX(TM)

Oncotype DX represents the first diagnostic multi-gene expression test service commercially available that has clinical evidence validating its ability to predict the likelihood of breast cancer recurrence, the likelihood of patient survival within 10 years of diagnosis and the likelihood of chemotherapy benefit. Oncotype DX has been extensively evaluated in multiple independent studies involving more than 2,600 breast cancer patients, including a large validation study published in The New England Journal of Medicine and a chemotherapy benefit study published in the Journal of Clinical Oncology. To date, over 6,000 physicians have ordered a cumulative total of more than 33,000 tests and approximat
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related medicine news :

1. Upcoming Hemogenomics Centre in Bangalore
2. Evoprinter, a multigenomic comparative tool for rapid identification of functionally important DNA
3. International Conference On Malaria - Laveran To Genomics
4. LINK Applied Genomics Programme Promises To Revolutionize Healthcare Systems
5. Nutrigenomics here comes a team to better your future!
6. Genomic tests for better cancer treatment
7. Web-Based Genomics Tool Designed to Help Predict Disease Susceptibility
8. AutoGenomics Addresses TB Crisis With a Genetic Drug Resistance Test
9. Pharmacogenomic Market Gaining Greater Acceptance Across Europe
10. Poor health care in Russia maybe causing Decline in its Population
11. Startling Expose – Physicians Often Have No Regular Source Of Health Car
Post Your Comments:
*Name:
*Comment:
*Email: